Acceleration of Medical Data Utilization: Milliman Becomes a 'Certified Processor of Pseudonymized Medical Information'
Milliman, a firm specializing in medical consulting and other services, has recently obtained certification as a "Certified Processor of Pseudonymized Medical Information." This is a significant milestone, marking only the second time a private company in Japan has received this certification.
"Pseudonymized medical information" refers to medical data that has been processed by removing names and other identifiers so that individuals cannot be identified without cross-referencing it with other information. Because it allows for the handling of more detailed information than the "anonymized medical information" used previously, it enables higher-precision analysis.
With this certification, the company will be able to further advance research into medical economics and treatment outcomes. This is expected to lead to the provision of more efficient and higher-quality medical services within Japan's healthcare sector.
Utilizing medical data is crucial for developing new drugs and preventing diseases while protecting individual privacy. As more companies begin to handle such data, it is anticipated that the development of Japan's medical technology and research will accelerate even further.